Search Within

Rachel Nicole Grisham

Formats
  1. Journal Article (80)
  2. Meeting Abstract (78)
  3. Review (9)
  4. Guidelines (3)
  5. Book Section (2)
  6. Editorial (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (175)
  2. GDMT, Medicine (175)
  3. Gynecologic Medicine Service (175)
  4. Gynecology Disease Management Team (175)
  5. Solid Tumor Oncology Division (175)
  6. Surgery (76)

More Groups

People
  1. Carol Aghajanian (87)
  2. Roisin O'Cearbhaill (68)
  3. Alexia Iasonos (63)
  4. Qin Zhou (56)
  5. Dennis Chi (52)
  6. Kara Long Roche (49)

More People

Years
  1. 2025 (13)
  2. 2024 (29)
  3. 2023 (26)
  4. 2022 (23)
  5. 2021 (12)
  6. 2020 (21)

More Years

Publications
  1. Gynecologic Oncology (49)
  2. Journal of Clinical Oncology (37)
  3. International Journal of Gynecological Cancer (28)
  4. Clinical Cancer Research (8)
  5. Cancer (7)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. Elsevier Inc. (50)
  2. American Society of Clinical Oncology (42)
  3. Lippincott Williams & Wilkins (30)
  4. American Association for Cancer Research (10)
  5. Wiley Blackwell (8)
  6. Nature Publishing Group (6)

More Publishers

Results (175)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 results of relacorilant + nabpaclitaxel in patients with recurrent, platinum-resistant ovarian cancer with and without prior bevacizumab
    Meeting Abstract

    Colombo, N.; Van Gorp, T.; Matulonis, U.; Oaknin, A.; Grisham, R.; Fleming, G.; Olawaiye, A.; Tudor, I. C.; Pashova, H.; Lorusso, D.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Molecular stratification of ovarian clear cell carcinoma predicts clinical outcomes
    Meeting Abstract

    Gordhandas, S.; Manning-Geist, B.; Hodgson, A.; Zhou, Q.; Iasonos, A.; Chi, D.; Momeni-Boroujeni, A.; Abu-Rustum, N.; Leitao, M.; Roche, K. L.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Overall survival data from a 3-arm, randomized, open-label, phase 2 study of relacorilant, a selective glucocorticoid receptor modulator, combined with nab-paclitaxel in patients with recurrent platinum-resistant ovarian cancer
    Meeting Abstract

    Colombo, N.; Van Gorp, T.; Matulonis, U. A.; Oaknin, A.; Grisham, R. N.; Fleming, G. F.; Olawaiye, A.; Pashova, H. I.; Nguyen, D. D.; Lorusso, D.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Postoperative morbidity after secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer: An exploratory analysis of a randomized phase II study evaluating hyperthermic intraperitoneal chemotherapy
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Chi, D.; Sonoda, Y.; Roche, K. L.; Gardner, G.; Tew, W.; Grisham, R.; O'Cearbhaill, R.; Zivanovic, O.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Oncologic outcomes of secondary cytoreductive surgery in the era of poly (ADP-ribose) polymerase inhibitors maintenance
    Meeting Abstract

    Ehmann, S.; Lam, C.; Zhou, Q.; Grisham, R.; Roche, K. L.; Zivanovic, O.; Sonoda, Y.; Chi, D.; Gardner, G.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Predicting outcomes in female germ cell patients using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
    Meeting Abstract

    Manning-Geist, B.; Deng, L.; Knezevic, A.; Bromberg, M.; Funt, S.; Zivanovic, O.; Roche, K. L.; Sonoda, Y.; Gardner, G.; Grisham, R.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • A preoperative tool for estimating the risk of blood transfusion over an ovarian cancer debulking surgery
    Meeting Abstract

    Kahn, R.; Boerner, T.; An, A.; Gardner, G.; Roche, K. L.; Sonoda, Y.; Zivanovic, O.; Grisham, R.; Abu-Rustum, N.; Chi, D.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Relacorilant + nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer: Phase II subgroup analysis mirroring the patient population of an upcoming phase III study
    Meeting Abstract

    Colombo, N.; Van Gorp, T.; Matulonis, U. A.; Oaknin, A.; Grisham, R. N.; Fleming, G.; Olawaiye, A.; Tudor, I. C.; Pashova, H. I.; Lorusso, D.
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Phase Ib study of elimusertib (ATRi; BAY 1895344) in combination with niraparib (PARPi) in patients with advanced solid tumors
    Meeting Abstract

    Yap, T. A.; Konstantinopoulos, P.; Grisham, R. N.; Gupta, D.; Wilkinson, G.; Cao, A.; Jeffers, M.; Sharma, N.
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Ovarian cancer mutational processes drive site-specific immune evasion
    Journal Article

    Vázquez-García, I.; Uhlitz, F.; Ceglia, N.; Lim, J. L. P.; Wu, M.; Mohibullah, N.; Niyazov, J.; Ruiz, A. E. B.; Boehm, K. M.; Bojilova, V.; more...
    Nature (2022)

    Fulltext@MSK | Save